Esomeprazole magnesium

(Nexium®)

Nexium®

Drug updated on 11/1/2023

Dosage FormCapsules (oral: 20 mg, 40 mg) Oral suspension (oral: 2.5 mg, 5 mg, 10 mg, 20 mg, and 40 mg)
Drug ClassProton pump inhibitor (PPI)
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • NEXIUM delayed-release capsules and NEXIUM for delayed-release oral suspension are indicated for the:
  • Short-term treatment in the healing of erosive esophagitis (EE) in adults and pediatric patients 12 years to 17 years of age.
  • Maintenance of healing of EE in adults.
  • Short-term treatment of heartburn and other symptoms associated GERD in adults and pediatric patients 12 years to 17 years of age.
  • Risk reduction of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults at risk for developing gastric ulcers due to age (60 years and older) and/or documented history of gastric ulcers.
  • Helicobacter pylori eradication in adult patients to reduce the risk of duodenal ulcer recurrence in combination with amoxicillin and clarithromycin.
  • Long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome in adults.
  • NEXIUM for delayed-release oral suspension is indicated for the:
  • Short-term treatment in the healing of EE in pediatric patients 1 year to 11 years of age and of EE due to acid-mediated GERD in pediatric patients 1 month to less than 1 year of age.
  • Short-term treatment of heartburn and other symptoms associated with GERD in pediatric patients 1 year to 11 years of age.